Recombinant Dichelobacter nodosus tRNA dimethylallyltransferase (miaA)

Shipped with Ice Packs
In Stock

Description

Protein Overview

  • Catalytic Function: Transfers a dimethylallyl group from dimethylallyl pyrophosphate (DMAPP) to the N⁶-position of adenosine-37 (A37) in tRNA, forming N⁶-isopentenyladenosine (i⁶A) .

  • Gene: Encoded by the miaA locus (UniProt ID: A5EXM7) .

  • Structure:

    • Contains a central substrate-binding channel for tRNA and DMAPP .

    • Features a conserved GxTxxGK(T/S) motif for pyrophosphate binding .

    • Structural homology to kinases suggests evolutionary divergence from farnesyltransferases .

Recombinant Production

Key expression systems and protein specifications:

ParameterDetails
Host SystemsMammalian cells, E. coli, Yeast, Baculovirus
Expression RegionFull-length (1-318 amino acids)
TagsVariable (determined during manufacturing; e.g., His-tag, AviTag)
Purity>85% (SDS-PAGE)
Storage-20°C to -80°C with glycerol stabilizers

tRNA Modification and Virulence

  • MiaA-mediated i⁶A-37 modification enhances codon-anticodon interactions, reducing frameshifting and translation errors .

  • In D. nodosus (a causative agent of ovine footrot), MiaA indirectly supports virulence by optimizing tRNA functionality for stress response and proteome regulation .

Phenotypic Impacts of MiaA Dysregulation

  • MiaA Deficiency:

    • Increases translational frameshifting .

    • Alters expression of virulence-associated proteins (e.g., proteases, fimbriae) .

  • Overexpression: Disrupts metabolic precursor availability, impairing stress adaptation .

Vaccine Development

  • While D. nodosus fimbrial proteins (e.g., FimA) are primary vaccine targets , MiaA’s role in tRNA modification highlights its potential as a regulatory checkpoint for virulence .

  • Recombinant MiaA is used to study post-transcriptional regulation in pathogenicity, though direct vaccine trials remain unexplored .

Comparative Genomic Insights

  • Conservation: MiaA homologues are widespread in prokaryotes, with functional conservation across species .

  • Virulence Association: Genomic analyses of D. nodosus isolates reveal bimodal population structures correlating with virulence, though MiaA itself is not a direct marker .

Challenges and Future Directions

  • Expression Toxicity: Recombinant MiaA production in E. coli requires optimized conditions to mitigate host-cell toxicity .

  • Therapeutic Potential: Targeting MiaA could disrupt bacterial translational fidelity, but specificity remains a challenge due to eukaryotic homologues .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies by purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Request dry ice shipment in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form shelf life is generally 6 months at -20°C/-80°C. Lyophilized form shelf life is generally 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
miaA; DNO_1117tRNA dimethylallyltransferase; EC 2.5.1.75; Dimethylallyl diphosphate:tRNA dimethylallyltransferase; DMAPP:tRNA dimethylallyltransferase; DMATase; Isopentenyl-diphosphate:tRNA isopentenyltransferase; IPP transferase; IPPT; IPTase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-318
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Dichelobacter nodosus (strain VCS1703A)
Target Names
miaA
Target Protein Sequence
MAAVITLIGA TASGKTDLAC ALYQRFPLRL ISVDSAQIYR GMDIGTAKPS AAFLKQYPHD LIDCCEPEEH YSAARFCQDA HQAIAKAHAD GKIPLLVGGT MLYYHALFSG LSDLPPADAQ LRAEIMAEMH TRGLPALYAD LLAYDPEQAN KIAANDTQRI IRFTELFRQT GQPPSALFAQ QKQAAPTWNS LHLALLPERH LLHQAIAQRF QTMMAAGFLE EVARLKMRPK LTAEHSSMRS VGYRQLWRHL DGEIDLETAV ELSIIATRQL AKRQITWLNN RLKTVLSMHF YDPYQAETPN RVFQQVAQFC KHNEGTFL
Uniprot No.

Target Background

Function
Catalyzes the transfer of a dimethylallyl group to the adenine at position 37 in tRNAs that read codons starting with uridine, forming N6-(dimethylallyl)adenosine (i(6)A).
Database Links
Protein Families
IPP transferase family

Q&A

What is tRNA dimethylallyltransferase (miaA) and what is its functional role in bacterial systems?

tRNA dimethylallyltransferase (miaA) is an enzyme (EC 2.5.1.75) that catalyzes the addition of a Δ2-isopentenyl group from dimethylallyl diphosphate to the N6-nitrogen of adenosine adjacent to the anticodon at position 37 of specific tRNA molecules. In Dichelobacter nodosus and other bacteria, this enzyme is responsible for the first step in a two-step modification pathway, creating i6A-37 in tRNAs that read codons beginning with U residues. This modification is further processed by the miaB gene product to form ms2i6A-37 .

The functional significance of this modification includes:

Research indicates that proper tRNA modification by miaA is particularly important for maintaining translation fidelity under various environmental conditions, potentially affecting the expression of numerous proteins including virulence factors .

What is the miaA mutator phenotype and how does it affect bacterial genetics?

The miaA mutator phenotype refers to the increased mutation rates observed in bacteria lacking functional miaA. This phenotype has several distinctive characteristics :

  • Mutation spectrum: miaA mutants primarily exhibit increased GC→TA transversion mutations

  • Recombination dependence: The mutator phenotype requires functional recombination systems, being suppressed in recA and recB mutants

  • Unique characteristics: Unlike Translation Stress-induced Mutagenesis (TSM), the miaA mutator phenotype is abolished by recD mutations and partially reduced by lexA(Ind-) mutations

The mechanistic basis of this mutator phenotype appears to be linked to decreased translation accuracy. When tRNAs lack the ms2i6A modification, translation errors increase, potentially affecting the synthesis of proteins involved in DNA replication and repair. This creates a cascade effect where translation errors lead to replication errors and increased mutation rates .

The table below summarizes key differences between miaA mutator phenotype and TSM:

CharacteristicmiaA Mutator PhenotypeTranslation Stress-induced Mutagenesis
Primary mutationsGC→TA transversionsAT→TA, AT→CG, GC→TA transversions
recA/recB dependenceYesYes
recD effectAbolishes mutator effectNo effect
lexA(Ind-) effectPartial reductionNo reduction

These findings suggest that while the miaA mutator phenotype shares some characteristics with TSM, it represents a distinct mechanism of mutagenesis in bacterial populations .

What experimental methods are recommended for studying miaA function in research settings?

Investigating miaA function requires a multi-disciplinary approach using several complementary methodologies:

Genetic Manipulation

  • Construction of miaA knockout mutants through insertional inactivation with selectable markers (e.g., tetM in D. nodosus)

  • Natural transformation for introducing mutations (used successfully with D. nodosus strain VCS1703A)

  • Complementation studies to confirm phenotype-genotype relationships

Gene Expression Analysis

  • RT-PCR for examining miaA transcript levels

  • RNA extraction using TRIzol followed by reverse transcription with specific primers

  • Verification of PCR products through sequencing

Proteomics Approaches

  • Multidimensional protein identification technology (MudPIT) or LC-MS/MS to characterize proteome changes in miaA mutants

  • Comparison of wild-type, miaA deletion, and miaA overexpression strains to identify differentially expressed proteins

Translation Fidelity Assays

  • Reporter systems to measure translational frameshifting in +1 and -1 directions

  • Analysis of codon-specific translation defects using specialized reporter constructs

tRNA Modification Analysis

  • Mass spectrometry to detect and quantify modified nucleosides in tRNA

  • In vitro modification assays with purified components to study enzyme kinetics

Carefully designed experimental controls are essential, including wild-type, mutant, and complemented strains. Standardized growth and testing conditions ensure reproducibility across experiments .

How should researchers properly store and handle recombinant D. nodosus miaA protein?

Proper storage and handling of recombinant D. nodosus tRNA dimethylallyltransferase is critical for maintaining enzyme activity:

Storage Conditions

  • Store at -20°C for routine storage

  • For extended storage, conserve at -20°C or -80°C

  • Shelf life of liquid form: approximately 6 months at -20°C/-80°C

  • Shelf life of lyophilized form: approximately 12 months at -20°C/-80°C

Handling Recommendations

  • Avoid repeated freezing and thawing cycles

  • Store working aliquots at 4°C for up to one week

  • Briefly centrifuge vials prior to opening to bring contents to the bottom

Reconstitution Protocol

  • Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% for long-term storage

  • The recommended default final concentration of glycerol is 50%

  • Prepare small aliquots to minimize freeze-thaw cycles

Quality Control Measures

  • Verify protein purity using SDS-PAGE (should be >85%)

  • Perform activity assays on freshly reconstituted protein to confirm functionality

  • Document lot numbers, preparation methods, and storage conditions

Following these guidelines helps ensure consistent and reliable experimental results when working with recombinant miaA protein.

How does miaA deficiency affect translation accuracy and frameshifting in bacteria?

miaA deficiency significantly impacts translation accuracy through several mechanisms that affect the decoding process:

Frameshifting Effects

Research demonstrates that miaA knockout leads to increased translational frameshifting in both directions:

  • In E. coli studies, miaA mutants show increased frameshifting in both +1 and -1 directions

  • This differs from earlier reports in K-12 E. coli strains that showed primarily +1 frameshifting

  • Overexpression of MiaA also affects frameshifting, particularly in the -1 direction

Codon-Specific Effects

The absence of ms2i6A-37 modification particularly affects the translation of codons beginning with U:

  • Reduced codon-anticodon stability leads to increased wobble and misreading

  • This creates codon-specific translation defects that can vary depending on mRNA context

Proteomic Consequences

MudPIT analysis reveals that miaA deletion significantly alters the bacterial proteome:

  • In E. coli studies, deletion of miaA led to downregulation of 115 proteins and upregulation of 34 proteins

  • These changes affect multiple cellular processes including metabolism and stress responses

The relationship between tRNA modification, translation accuracy, and proteome composition demonstrates how a single modification enzyme can have far-reaching effects on bacterial physiology and adaptation to environmental conditions .

What experimental designs are most appropriate for studying the effects of miaA mutations?

When designing experiments to study miaA mutations, researchers should consider several key methodological approaches:

Comparative Experimental Design

The most effective design involves parallel analysis of:

  • Wild-type strain (positive control)

  • miaA deletion mutant

  • Complemented mutant (for confirming phenotype is due to miaA)

  • miaA overexpression strain (to assess dose-dependent effects)

Control Variable Selection

Successful experimental designs must control for:

  • Growth conditions (temperature, media composition, growth phase)

  • Genetic background (using isogenic strains)

  • Expression levels of complementing genes

  • Potential polar effects on downstream genes

Phenotypic Assessment Methods

For comprehensive characterization, include multiple phenotypic readouts:

  • Growth curve analysis under various conditions

  • Protease activity measurements (particularly relevant for D. nodosus)

  • Reporter systems for measuring translational accuracy

  • Virulence testing in appropriate models

Statistical Considerations

Statistical rigor requires:

  • Sufficient biological replicates (minimum n=3)

  • Technical replicates for each measurement

  • Appropriate statistical tests based on data distribution

  • Power analysis to determine sample size requirements

Cross-Validation Approaches

  • Use multiple independent methods to assess the same phenotype

  • Verify genetic manipulations through sequencing and expression analysis

  • Compare results across different growth conditions or genetic backgrounds

This comprehensive experimental design approach ensures robust and reproducible findings when investigating the complex effects of miaA mutations on bacterial physiology and pathogenesis .

How can researchers effectively express and purify recombinant D. nodosus miaA?

Effective expression and purification of recombinant D. nodosus tRNA dimethylallyltransferase (miaA) can be achieved through several expression systems, each with specific advantages:

Expression Systems Comparison

Expression SystemAdvantagesConsiderationsYield
E. coliRapid growth, simple media, well-established protocolsMay lack post-translational modificationsHigh
YeastEukaryotic processing, shorter turnaround than mammalian systemsMore complex media requirementsModerate to high
Baculovirus/insect cellsGood post-translational modifications, high yieldLonger preparation time, more technical complexityModerate to high
Mammalian cellsBest for complex post-translational modificationsLongest preparation time, most expensiveLow to moderate

Commercially available recombinant D. nodosus miaA is expressed in mammalian cells, suggesting this system produces properly folded, functional protein .

Purification Strategy

  • Express full-length protein (318 amino acids for D. nodosus strain VCS1703A)

  • Include appropriate affinity tags for purification (tag type determined during manufacturing process)

  • Perform initial capture using affinity chromatography

  • Apply polishing steps (ion exchange, size exclusion) to achieve >85% purity (as verified by SDS-PAGE)

Quality Control

  • Verify protein identity by mass spectrometry or Western blotting

  • Assess purity by SDS-PAGE (should exceed 85%)

  • Confirm activity through enzymatic assays

  • Test protein stability under storage conditions

The choice of expression system should be guided by research requirements, including needed post-translational modifications and downstream applications .

What is the relationship between miaA function and bacterial virulence?

The relationship between miaA function and bacterial virulence is multifaceted and involves several interconnected mechanisms:

Translation Quality Control and Virulence

miaA-mediated tRNA modifications enhance translation accuracy, which directly affects:

  • Proper synthesis of virulence factors

  • Expression of stress response proteins needed during infection

  • Maintenance of bacterial fitness in host environments

Specific Virulence Connections

In Dichelobacter nodosus, the causative agent of footrot in sheep:

  • Virulence is associated with extracellular protease production

  • These proteases play key roles in tissue invasion and nutrient acquisition

  • Translation accuracy likely influences the proper expression of these virulence determinants

Experimental Evidence

Studies of D. nodosus have demonstrated:

  • The strain VCS1703A (which possesses miaA) displays characteristics associated with virulent isolates

  • It was elastase positive after 7-10 days on elastin agar

  • It tested positive in gelatin-gel protease stability tests

  • In preliminary pen virulence trials, it produced virulent footrot in sheep

Evolutionary Implications

The connection between tRNA modification and virulence suggests:

  • tRNA modification systems may have evolved partly to optimize virulence gene expression

  • Environmental adaptation and virulence may be linked through translation quality control

  • These systems could represent targets for antimicrobial development

While direct experimental evidence specifically linking miaA to virulence in D. nodosus is still developing, the established connection between translation accuracy and proper protein expression strongly suggests that miaA plays an important role in virulence factor production and bacterial pathogenesis .

How does the biochemical mechanism of miaA catalysis work and what factors affect enzyme activity?

The biochemical mechanism of tRNA dimethylallyltransferase (miaA) catalysis involves several coordinated steps and specific requirements:

Catalytic Mechanism

  • Substrate recognition and binding: miaA specifically recognizes tRNAs that read codons beginning with U and binds both the tRNA and dimethylallyl diphosphate (DMAPP)

  • Nucleophilic substitution: The enzyme catalyzes the transfer of a dimethylallyl group from DMAPP to the N6-nitrogen of adenosine at position 37

  • Product formation: This creates i6A-37 in the target tRNAs, which can then serve as a substrate for further modification by miaB

Enzymatic Requirements

  • Divalent metal ions: Typically Mg2+ is required for optimal activity

  • Nucleotide-binding motifs: The TASGKT sequence in D. nodosus miaA is involved in DMAPP binding

  • Specific pH range: Optimal activity occurs within a defined pH range, typically 7.5-8.0

Factors Affecting Enzyme Activity

  • Temperature: Enzyme activity typically increases with temperature up to an optimal point

  • Ionic strength: Buffer composition and salt concentration affect activity

  • Substrate availability: Both tRNA and DMAPP concentrations influence reaction rates

  • Product inhibition: Accumulation of modified tRNA or diphosphate byproduct may inhibit further catalysis

Structure-Function Relationships

The D. nodosus miaA protein contains several key structural elements:

  • N-terminal nucleotide-binding region with the TASGKT motif

  • Central catalytic domain containing residues involved in tRNA recognition

  • Regions responsible for positioning the adenosine substrate for modification

Understanding these mechanistic details provides insights into enzyme function and offers potential avenues for developing specific inhibitors that could target bacterial tRNA modification pathways .

What advanced research techniques are available for studying miaA-dependent tRNA modifications?

Advanced research techniques for studying miaA-dependent tRNA modifications span multiple disciplines and technological approaches:

High-Resolution Mass Spectrometry

  • Liquid chromatography-mass spectrometry (LC-MS) for precise identification and quantification of modified nucleosides

  • Comparative analysis of tRNA modifications between wild-type and miaA mutant strains

  • Tandem mass spectrometry (MS/MS) for structural characterization of novel modifications

Next-Generation Sequencing Applications

  • tRNA-seq for comprehensive profiling of tRNA populations and their modifications

  • HITS-CLIP (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation) to study tRNA-protein interactions

  • Ribosome profiling to identify translation defects at specific codons in miaA mutants

Advanced Imaging Techniques

  • Cryo-electron microscopy for structural analysis of miaA-tRNA complexes

  • Single-molecule fluorescence resonance energy transfer (FRET) to study enzyme-substrate interactions in real-time

  • Super-resolution microscopy to visualize the cellular localization of miaA and related enzymes

Computational Biology Approaches

  • Molecular dynamics simulations to study the structural basis of miaA function

  • Systems biology modeling to understand the global effects of tRNA modifications

  • Machine learning algorithms to predict tRNA modification sites and their functional impacts

Novel Experimental Systems

  • In vitro reconstitution of complete tRNA modification pathways

  • Cell-free translation systems to directly measure the effects of specific modifications

  • CRISPR-Cas9 genome editing for precise manipulation of miaA and related genes

These advanced techniques enable researchers to gain unprecedented insights into the mechanistic details and biological significance of miaA-dependent tRNA modifications across bacterial species .

How do experimental designs for studying miaA differ between in vitro and in vivo approaches?

Research on tRNA dimethylallyltransferase (miaA) employs distinctly different experimental designs for in vitro and in vivo approaches, each with specific advantages and limitations:

In Vitro Experimental Approaches

ApproachMethodologyAdvantagesLimitations
Enzyme kineticsPurified miaA, tRNA substrates, DMAPP; spectrophotometric assaysPrecise control of reaction conditions; quantitative measurement of enzyme parametersLacks cellular context; may not reflect in vivo activity
Structural studiesX-ray crystallography; cryo-EM; NMRDetailed structural information; insights into catalytic mechanismStatic snapshots; may not capture dynamic interactions
Reconstitution assaysCombination of purified components to recreate modification pathwayDefines minimal requirements for activity; identifies cofactor dependenciesSimplified system lacks regulatory factors present in cells

In Vivo Experimental Approaches

ApproachMethodologyAdvantagesLimitations
Genetic studiesGene knockout; complementation; overexpressionReveals phenotypic consequences in cellular contextPotential for indirect effects; compensatory mechanisms
Virulence testingAnimal models (e.g., sheep for D. nodosus)Directly assesses role in pathogenesisEthical considerations; resource intensive; variability
tRNA modification profilingLC-MS analysis of cellular tRNAMeasures actual modification levels in living cellsCannot distinguish direct from indirect effects
ProteomicsMudPIT or LC-MS/MS analysisComprehensive view of protein expression changesComplex data interpretation; downstream effects

Bridging the Gap Between Approaches

Effective research designs incorporate both in vitro and in vivo approaches:

  • Initial in vitro characterization establishes basic enzyme properties

  • In vivo studies validate biological relevance and identify phenotypes

  • Return to refined in vitro studies to investigate specific mechanisms

  • Develop integrated models that explain both biochemical and biological observations

This iterative approach provides a more complete understanding of miaA function than either approach alone, connecting molecular mechanisms to biological outcomes in bacterial systems .

What are the current methodological challenges in researching tRNA modifications like those catalyzed by miaA?

Research on tRNA modifications like those catalyzed by miaA faces several significant methodological challenges:

Analytical Limitations

  • Detection sensitivity: Modified nucleosides often exist in low abundance, requiring highly sensitive detection methods

  • Structural similarity: Some modifications have very similar chemical structures, making them difficult to distinguish analytically

  • Sample preparation: tRNA isolation protocols may result in modification loss or damage, creating artifacts

Experimental Design Challenges

  • Genetic redundancy: Bacteria may have compensatory pathways that mask phenotypes of single modification enzyme mutations

  • Pleiotropic effects: Modification defects can affect multiple cellular processes, complicating interpretation

  • Growth condition dependencies: Some phenotypes only manifest under specific environmental conditions

Technical Hurdles

  • Expression systems: Producing properly folded, active recombinant modification enzymes like miaA can be technically challenging

  • Assay development: Creating reliable, quantitative assays for specific tRNA modifications requires specialized expertise

  • Model system limitations: Results in laboratory strains may not translate to clinical isolates or in vivo situations

Data Integration Challenges

  • Multi-omics integration: Connecting tRNA modification data with transcriptomics, proteomics, and phenomics remains difficult

  • Bioinformatic tools: Limited availability of specialized computational tools for analyzing tRNA modification datasets

  • Standardization issues: Lack of standardized methods makes cross-study comparisons challenging

Addressing these challenges requires multidisciplinary approaches and continued methodological innovation. Developing standardized protocols, improving detection sensitivity, and creating better computational tools will significantly advance our understanding of tRNA modifications and their biological significance .

How can researchers design experiments to investigate the effect of miaA on translation fidelity?

Designing experiments to investigate miaA's effect on translation fidelity requires specialized approaches that can detect and quantify translation errors:

Reporter System Design

  • Frameshifting reporters:

    • Dual luciferase constructs with test and control luciferases

    • Insertion of frameshifting sequences between the luciferases

    • Measurement of both +1 and -1 frameshifting rates

    • Comparison between wild-type, miaA mutant, and complemented strains

  • Nonsense suppression systems:

    • Reporters with premature stop codons in measurable proteins

    • Quantification of readthrough events

    • Analysis of codon context effects on suppression efficiency

Experimental Variables to Control

  • Growth conditions: Phase, temperature, media composition

  • Expression levels: For complementation and overexpression studies

  • Strain background: Use isogenic strains differing only in miaA status

  • Plasmid copy number: For reporter constructs

Proteome-Wide Approaches

  • Mass spectrometry-based error detection:

    • Identification of amino acid substitutions in the proteome

    • Quantification of error rates at specific codons

    • Correlation with tRNA modification status

  • Ribosome profiling:

    • Analysis of ribosome stalling at specific codons

    • Comparison between wild-type and miaA mutant strains

    • Assessment of translation efficiency for different codon contexts

Statistical Analysis Considerations

  • Biological replicates: Minimum of three independent experiments

  • Technical replicates: Multiple measurements per biological replicate

  • Normalization methods: To account for differences in growth or expression

  • Statistical tests: Appropriate for data distribution and experimental design

Data Presentation Format

  • Comprehensive tables showing frameshifting rates across different reporters

  • Bar graphs comparing error rates between strains and conditions

  • Statistical significance indicators to highlight meaningful differences

This comprehensive experimental approach allows researchers to quantify and characterize the specific effects of miaA on various aspects of translation fidelity, providing insights into how tRNA modifications influence protein synthesis accuracy .

What recent methodological advances have improved the study of recombinant miaA and its applications?

Recent methodological advances have significantly enhanced the study of recombinant miaA and expanded its research applications:

Expression and Purification Innovations

  • Optimized expression systems: Development of specialized bacterial strains for improved protein folding and reduced proteolytic degradation

  • Fusion tag technology: Novel affinity tags and cleavage methods for higher purity and yield

  • High-throughput purification platforms: Automated systems allowing parallel processing of multiple protein variants

Structural Biology Advances

  • Cryo-electron microscopy: Near-atomic resolution structures of tRNA modification enzymes and their complexes

  • Time-resolved crystallography: Capturing intermediate states during the catalytic cycle

  • Hydrogen-deuterium exchange mass spectrometry: Mapping protein dynamics and conformational changes during substrate binding

Functional Analysis Tools

  • Real-time enzyme assays: Fluorescence-based methods for continuous monitoring of miaA activity

  • Single-molecule techniques: Direct observation of enzyme-substrate interactions and catalytic events

  • Nanopore technology: Detection of modified nucleosides in tRNA with single-molecule resolution

Genetic Engineering Approaches

  • CRISPR-Cas9 genome editing: Precise manipulation of miaA and related genes in diverse bacterial species

  • Inducible expression systems: Tight control of miaA expression levels for dose-response studies

  • Site-saturation mutagenesis: Comprehensive analysis of structure-function relationships

Computational Methods

  • Molecular dynamics simulations: Modeling enzyme-substrate interactions at atomic resolution

  • Machine learning algorithms: Prediction of modification sites and functional impacts

  • Systems biology approaches: Integration of multi-omics data to understand global effects of tRNA modifications

These methodological advances collectively enable more precise, comprehensive, and high-throughput studies of miaA function, accelerating our understanding of tRNA modifications and their biological significance across bacterial species .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.